Skip to main content

Posts

Showing posts with the label DRUG POLICY

Senior Financial Controller-University of Luxembourg

  Published on 06/04/2025 Luxembourg (Canton), Luxembourg Education / Training Working time Full-time Type of contract Permanent contract Professional experience Beginner (less than 1 year) Educational level Master About the FDEF The  University of Luxembourg  is an international research university with a distinctly multilingual and interdisciplinary character. Senior Financial Controller-University of Luxembourg The  Faculty of Law, Economics and Finance  (FDEF) at the University of Luxembourg offers a unique academic and research environment. Rooted in Luxembourg but with a European and international outlook,  teaching  and research benefit from the proximity of the European institutions, Luxembourg's leading international financial  centre  and its vibrant business community. Institutional and private sector partnerships, sponsored Chairs and a growing network of international partner universities make the FDEF a dynamic academic hub at t...

Don’t compound tragic effect of COVID-19 on HIV

Don’t compound tragic effect of COVID-19 on HIV The silent tragedy of the COVID-19 pandemic is its devastating impact on people with  other  health conditions. For those illnesses, declining attention has persisted even as the threat of COVID-19 is declining. HIV provides a striking example of the setback — and how the effects are looming in the shadows. In December, President  Biden  set a goal of  reducing new HIV infections  to just 3,000 a year by 2030, a decline of more than 90 percent from current levels. That goal is achievable as long as Congress and the administration are putting the right policies in place and people can access and afford their medications. Before the COVID-19 pandemic, efforts to  reduce HIV  in America was meeting some success — for a combination of reasons, including the mobilization of resources to get people tested and into care and the development of improved antiretrovirals for treatment and of PrEP for prevention...